Additionally, the upregulation of LPL, FATP2, and CPT1A, which are essential enzymes involved in FA metabolism, is directly correlated with tumor aggressiveness and lymph node metastases, making these viable biomarkers for PTC prognosis. This evidence concerns the gene SLC27A2 and neoplasm.